Quidel Gains 80% Margin Potential With Litmus' Multi-Layered Film Testing
This article was originally published in The Gray Sheet
Executive Summary
Integration of Litmus Concepts' multi-layered film testing technology into Quidel's existing diagnostics portfolio will give Quidel an opportunity to achieve gross margins of over 80%, up from about 55% with its existing lateral flow immunoassay platform.